糖基化在输血医学、血小板和红细胞中的多方面作用
本综述阐述糖基化这一复杂翻译后修饰在输血医学、止血与血栓形成及红细胞和血小板存活中的作用。糖链多样性影响蛋白质降解与清除、细胞运输、信号传导、宿主-病原体相互作用及免疫防御;ABO(H)抗原对输血和器官移植相容性至关重要,糖基因突变可导致严重血液病并影响血小板计数。
要点
- 糖链多样性影响蛋白质降解与清除、细胞运输、信号传导及免疫防御等多种生物学功能。
- ABO(H)抗原对输血和器官移植的产品相容性至关重要,其表达可能影响心血管疾病、血栓形成和止血障碍。
- PIGA、COSMC等糖基因突变可导致Tn综合征等严重血液病;GNE、GALE、B4GALT1基因改变可深刻影响循环血小板计数。
核心结论
- 本综述阐述糖链在输血医学、止血与血栓形成以及红细胞和血小板存活中的作用。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 糖链多样性参与蛋白质降解、蛋白质清除、细胞运输、细胞信号传导、宿主-病原体相互作用以及包括先天性和获得性免疫在内的免疫防御。
- 糖链ABO(H)抗原在输血和器官移植中为提供相容性产品至关重要;证据还提示ABO表达可能影响心血管疾病、血栓形成和止血障碍,包括血小板功能改变和von Willebrand因子血液水平变化。
- 糖基因PIGA、COSMC突变导致严重血液病,包括与高凝集、溶血和血小板减少相关的Tn综合征。
- 参与唾液酸(Sia)合成的GNE基因以及UDP-半乳糖(GALE)和乳糖胺(LacNAc)(B4GALT1)相关基因的改变深刻影响循环血小板计数。
- 去唾液酸化(唾液酸去除)受人类和病原性神经氨酸酶影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glycosylation is highly prevalent, and also one of the most complex and varied posttranslational modifications. This large glycan diversity results in a wide range of biological functions. Functional diversity includes protein degradation, protein clearance, cell trafficking, cell signaling, host-pathogen interactions, and immune defense, including both innate and acquired immunity. Glycan-based ABO(H) antigens are critical in providing compatible products in the setting of transfusion and organ transplantation. However, evidence also suggests that ABO expression may influence cardiovascular disease, thrombosis, and hemostasis disorders, including alterations in platelet function and von Willebrand factor blood levels. Glycans also regulate immune and hemostasis function beyond ABO(H) antigens. Mutations in glycogenes (PIGA, COSMC) lead to serious blood disorders, including Tn syndrome associated with hyperagglutination, hemolysis, and thrombocytopenia. Alterations in genes responsible for sialic acids (Sia) synthesis (GNE) and UDP-galactose (GALE) and lactosamine (LacNAc) (B4GALT1) profoundly affect circulating platelet counts. Desialylation (removal of Sia) is affected by human and pathogenic neuraminidases. This review addresses the role of glycans in transfusion medicine, hemostasis and thrombosis, and red blood cell and platelet survival.
引用
- Lee-Sundlov MM, Stowell SR, Hoffmeister KM, et al. Multifaceted role of glycosylation in transfusion medicine, platelets, and red blood cells. J Thromb Haemost. 2020. PMID: 32350996. doi:10.1111/jth.14874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。